Khartis Therapeutics | RoundOS

Weekly digest by email

Loading companies…

Khartis Therapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Aug 13, 2026	Series B	$50M	Alexandria Venture Investments — Role not disclosedForesite Capital — Role not disclosedForge Life Science Partners — Role not disclosedLilly Asia Ventures — Role not disclosedLongwood Fund — Role not disclosedNextech Invest — Role not disclosed

Investors

Alexandria Venture InvestmentsSeries B Foresite CapitalSeries B Forge Life Science PartnersSeries B Lilly Asia VenturesSeries B Longwood FundSeries B Nextech InvestSeries B

Coverage

Aug 13, 2026Khartis Therapeutics · Series B

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

khartis.com ↗